Lyons, KE, JH Friedman, N Hermanowicz, SH Isaacson, RA Hauser, BP Hersh, DE Silver, et al. 2010. “Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects”. Clin Neuropharmacol. Last updated on 11/04/2024
